Tianyi Li, n/a

Xiamen Amoytop Biotech Co., Ltd
Shanghai, China (People's Republic)

Disclosure information not submitted.

Presentation(s):

• MON-228 - Dose Adjustment Strategy for the Long-Acting Growth Hormone Pegpesen Based on IGF-1 Level: A Poppk/PD Simulation Study

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT